Antonijoan R - Search Results

1

Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort.

Corominas H, Castellví I, Pomar V, Antonijoan R, Mur I, Matas L, Gich I, de Benito N, Laiz A, Castillo D, Villamarin L, Filella D, Millán AM, Quijada MÁ, Puig M, Casademont J, Domingo P. Corominas H, et al. Among authors: antonijoan r. Clin Immunol. 2021 Feb;223:108631. doi: 10.1016/j.clim.2020.108631. Epub 2020 Nov 12. Clin Immunol. 2021. PMID: 33189888 Free PMC article.

2

Clinical pharmacokinetics of dexketoprofen.

Barbanoj MJ, Antonijoan RM, Gich I. Barbanoj MJ, et al. Among authors: antonijoan rm. Clin Pharmacokinet. 2001;40(4):245-62. doi: 10.2165/00003088-200140040-00002. Clin Pharmacokinet. 2001. PMID: 11368291 Review.

3

Comparison of repeated-dose pharmacokinetics of prolonged-release and immediate-release torasemide formulations in healthy young volunteers.

Barbanoj MJ, Ballester MR, Antonijoan RM, Gich I, Pelagio P, Gropper S, Santos B, Guglietta A. Barbanoj MJ, et al. Among authors: antonijoan rm. Fundam Clin Pharmacol. 2009 Feb;23(1):115-25. doi: 10.1111/j.1472-8206.2008.00643.x. Fundam Clin Pharmacol. 2009. PMID: 19267775 Clinical Trial.

4

Grounds for the integration of pharmacokinetic-pharmacodynamic data.

Barbanoj MJ, Salazar G, Morte A, Antonijoan RM, Gich I, Jané F. Barbanoj MJ, et al. Among authors: antonijoan rm. Methods Find Exp Clin Pharmacol. 1996;18 Suppl C:43-5. Methods Find Exp Clin Pharmacol. 1996. PMID: 9003577 No abstract available.

5

Pharmacokinetics of dexketoprofen trometamol in healthy volunteers after single and repeated oral doses.

Barbanoj MJ, Gich I, Artigas R, Tost D, Moros C, Antonijoan RM, García ML, Mauleón D. Barbanoj MJ, et al. Among authors: antonijoan rm. J Clin Pharmacol. 1998 Dec;38(S1):33S-40S. J Clin Pharmacol. 1998. PMID: 9882080 Clinical Trial.

6

A study comparing the inhibitory effects of single and repeated oral doses of ebastine and fexofenadine against histamine-induced skin reactivity.

Barbanoj MJ, Antonijoan RM, García-Gea C, Morte A, Gich I, Gispert J, Garcia E, Esbrí R, Luria X. Barbanoj MJ, et al. Among authors: antonijoan rm. Int Arch Allergy Immunol. 2003 Nov;132(3):263-7. doi: 10.1159/000074308. Int Arch Allergy Immunol. 2003. PMID: 14646388 Clinical Trial.

7

Glomerular hyperfiltration, intrarenal hemodynamics, and chronic allograft nephropathy: physiopathology of chronic allograft nephropathy.

Solà R, Paredes D, Antonijoan RM, Estorch M, Vila LP, Guirado LL, Diaz JM, Gich I, Barbanoj MJ. Solà R, et al. Among authors: antonijoan rm. Transplant Proc. 2002 Feb;34(1):340-2. doi: 10.1016/s0041-1345(01)02790-7. Transplant Proc. 2002. PMID: 11959315 No abstract available.

8

Stress assessment based on EEG univariate features and functional connectivity measures.

Alonso JF, Romero S, Ballester MR, Antonijoan RM, Mañanas MA. Alonso JF, et al. Among authors: antonijoan rm. Physiol Meas. 2015 Jul;36(7):1351-65. doi: 10.1088/0967-3334/36/7/1351. Epub 2015 May 27. Physiol Meas. 2015. PMID: 26015439

9

Basics of PK-PD using QEEG: acute/repetitive administration, interactions. Focus on anxiolytics with different neurochemical mechanisms as examples.

Barbanoj MJ, Riba J, Morte A, Antonijoan RM, Jané F. Barbanoj MJ, et al. Among authors: antonijoan rm. Methods Find Exp Clin Pharmacol. 2002;24 Suppl C:67-83. Methods Find Exp Clin Pharmacol. 2002. PMID: 12575490 Review.

10

Quantifying drug-drug interactions in pharmaco-EEG.

Barbanoj MJ, Antonijoan RM, Riba J, Valle M, Romero S, Jané F. Barbanoj MJ, et al. Among authors: antonijoan rm. Clin EEG Neurosci. 2006 Apr;37(2):108-20. doi: 10.1177/155005940603700208. Clin EEG Neurosci. 2006. PMID: 16733942 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page